Cargando…
End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?
Context Patients with seminoma present with advanced disease. End-of-treatment (EOT) positron emission tomography-computed tomography (PET-CT) is done to assess response and direct management of post-chemotherapy residual masses. Purpose This article assesses the utility of EOT PET-CT in the manag...
Autores principales: | Joel, Anjana, Singh, Ashish, Hepzibah, Julie, Devasia, Antony, Kumar, Santosh, Gnanamuthu, Birla Roy, Chandramohan, Anuradha, George, Arun Jacob Philip, John, Nirmal Thampi, Yadav, Bijesh, John, Ajoy Oommen, Georgy, Josh Thomas, John, Subhashini, Chacko, Raju Titus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902077/ https://www.ncbi.nlm.nih.gov/pubmed/36756102 http://dx.doi.org/10.1055/s-0041-1735480 |
Ejemplares similares
-
Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting
por: Joel, Anjana, et al.
Publicado: (2021) -
Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome
por: Sharma, Parth, et al.
Publicado: (2022) -
Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021) -
The interfaces of lanthanum oxide-based subnanometer EOT gate dielectrics
por: Wong, Hei, et al.
Publicado: (2014) -
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India
por: Joel, Anjana, et al.
Publicado: (2021)